These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9443609)
21. [Feasibility of subrenal capsule assay as chemosensitivity test for primary esophageal cancer]. Fukui H Nihon Kyobu Geka Gakkai Zasshi; 1989 Jun; 37(6):1121-30. PubMed ID: 2809285 [TBL] [Abstract][Full Text] [Related]
22. [Effects of gonadotropin on the growth of malignant ovarian neoplasms assessed by subrenal capsule assay]. Ohtani K Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jun; 42(6):579-85. PubMed ID: 2119409 [TBL] [Abstract][Full Text] [Related]
23. [Subrenal capsule assay--an experimental study and clinical application to chemosensitivity tests]. Inoue K; Wang Y; Shibata H; Ueno K; Itoh Y; Tada A; Wada T; Mukaiyama T; Mitsui I; Ogawa M Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1629-35. PubMed ID: 3592706 [TBL] [Abstract][Full Text] [Related]
24. [An experimental study on SRCA (subrenal capsule assay)--comparison of the test between normal and nude mice]. Kikuchi H; Asamura M; Gamoh M; Matsushita T; Chen DY; Wakui A; Takahashi T Gan To Kagaku Ryoho; 1988 Mar; 15(3):499-504. PubMed ID: 3348635 [TBL] [Abstract][Full Text] [Related]
25. Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay. Stratton JA; Mannel RS; Rettenmaier MA; Berman ML; DiSaia PJ Gynecol Oncol; 1989 Jan; 32(1):55-9. PubMed ID: 2535831 [TBL] [Abstract][Full Text] [Related]
26. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I. Mäenpää J; Kangas L; Grönroos M Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908 [TBL] [Abstract][Full Text] [Related]
27. Chemosensitivity of human melanoma metastases in mouse subrenal capsule assay--can it predict tumour response to combined cytostatic plus interferon therapy in metastatic melanoma? Hahka-Kemppinen M; Muhonen T; Kangas L; Pyrhönen S Melanoma Res; 1996 Jun; 6(3):215-21. PubMed ID: 8819124 [TBL] [Abstract][Full Text] [Related]
28. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812 [TBL] [Abstract][Full Text] [Related]
29. The subrenal capsule assay for chemosensitivity testing of tumors. A review. Mäenpää J; Kangas L; Grönroos M Zentralbl Gynakol; 1988; 110(16):989-96. PubMed ID: 3055756 [TBL] [Abstract][Full Text] [Related]
30. The subrenal capsule assay (SRCA) and its predictive value in oncology. Bogden AE Ann Chir Gynaecol Suppl; 1985; 199():12-27. PubMed ID: 3904584 [TBL] [Abstract][Full Text] [Related]
31. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome. Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801 [TBL] [Abstract][Full Text] [Related]
32. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II. Mäenpää J Obstet Gynecol; 1985 Nov; 66(5):714-8. PubMed ID: 3903584 [TBL] [Abstract][Full Text] [Related]
33. Drug-sensitivity testing in patients with human oesophageal squamous cell carcinoma. Terashima M; Ikeda K; Maesawa C; Kawamura H; Ishida K; Sato M; Saito K Eur J Cancer; 1992; 28A(8-9):1347-50. PubMed ID: 1515248 [TBL] [Abstract][Full Text] [Related]
34. [Application of the 6-day subrenal capsule assay for sensitivity testing of antineoplastic chemotherapy in oral mucosa carcinoma]. Fröhlich M; Rositzka R; Neubauer B Zahn Mund Kieferheilkd Zentralbl; 1989; 77(5):427-32. PubMed ID: 2529712 [TBL] [Abstract][Full Text] [Related]
35. [Subrenal capsule assay (SRCA) using human lung cancer]. Kudoh S; Kurihara N; Mizoguchi S; Ueda Y; Adachi N; Hiraga T; Yamamoto M; Hirata K; Ohta K; Fujimoto S Gan To Kagaku Ryoho; 1988 Sep; 15(9):2743-9. PubMed ID: 3415270 [TBL] [Abstract][Full Text] [Related]
36. [Fundamental study of subrenal capsule assay by measuring specific activity of succinate dehydrogenase]. Munakata H; Kawahara M; Kayada Y; Sakamoto T; Takada K Gan To Kagaku Ryoho; 1992 Feb; 19(2):217-22. PubMed ID: 1371048 [TBL] [Abstract][Full Text] [Related]
37. Chemosensitivity tests in colorectal cancer patients. Yanagawa E; Nishiyama M; Saeki T; Kim R; Jinushi K; Kirihara Y; Takagami S; Niimoto M; Hattori T Jpn J Surg; 1989 Jul; 19(4):432-8. PubMed ID: 2810957 [TBL] [Abstract][Full Text] [Related]
38. The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment. Aamdal S; Fodstad O; Pihl A Ann Chir Gynaecol Suppl; 1985; 199():51-9. PubMed ID: 3864392 [TBL] [Abstract][Full Text] [Related]
39. [The clinical assessment of the results of predicting individual sensitivity to adjuvant chemotherapy in lung tumors]. Sergeeva NS; Skotnikova OI; Chissov VI; Borisov VI; Trakhtenberg AKh; Bil'danova LA; Pelevina II Vopr Onkol; 1992; 38(9):1062-5. PubMed ID: 1338676 [TBL] [Abstract][Full Text] [Related]